How should I use Mektovi(Binimetinib)?

The recommended dose of Binimetinib is 45 mg orally, twice daily, with or without food.

Dosage and Administration for Binimetinib Tablets

The recommended dose of Binimetinib Tablets (15 mg) for ad is 45 mg orally, twice daily, with or without food. Treatment should be administered consistently to maintain therapeutic efficacy. The dose for pediatric patients may vary based on medical guidance and individual factors like body surface area. It is important to monitor patients for adverse reactions, including hepatic toxicity and gastrointestinal side effects, which may require dose adjustments or discontinuation. Patients should adhere to the prescribed schedule and report any side effects promptly for appropriate management.

Related Columns

Binimetinib(Mektovi)

Adults with advanced or metastatic melanoma with BRAF V600E or V600K mutation.

WeChat Scan
Free Inquiry

Dosage and Administration, Recommended Dose of Binimetinib (Mektovi)

Binimetinib (Mektovi) is a kinase inhibitor, usually used in combination with encorafenib, for the treatment of unresectable or metastatic melanoma positive for BRAF V600E or V600K mutations, as well ...

Dosage and precautions for Binimetinib

Binimetinib is a targeted therapy drug that is primarily used to treat patients with advanced melanoma who carry specific gene mutations. The drug prevents the growth and spread of diseased cells by i...

Guidelines for the administration of Binimetinib

Binimetinib is a drug used to treat certain types of diseases, especially melanoma associated with specific gene mutations, and belongs to a class of drugs called MEK inhibitors that stop the gro...